Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adalimumab and methotrexate affect the concentrations of regulatory cytokines (interleukin-10, transforming growth factor-β1, and interleukin-35) in patients with plaque psoriasis.
Zdanowska N, Owczarczyk-Saczonek A, Czerwińska J, Nowakowski JJ, Kozera-Żywczyk A, Owczarek W, Zdanowski W, Placek W. Zdanowska N, et al. Among authors: owczarek w. Dermatol Ther. 2020 Nov;33(6):e14153. doi: 10.1111/dth.14153. Epub 2020 Sep 14. Dermatol Ther. 2020. PMID: 32770629
Secondary failure of TNF-α inhibitors in clinical practice.
Owczarczyk-Saczonek A, Owczarek W, Osmola-Mańkowska A, Adamski Z, Placek W, Rakowska A. Owczarczyk-Saczonek A, et al. Among authors: owczarek w. Dermatol Ther. 2019 Jan;32(1):e12760. doi: 10.1111/dth.12760. Epub 2018 Nov 18. Dermatol Ther. 2019. PMID: 30288872 Review.
Clinicopathologic retrospective analysis of annular pustular psoriasis.
Owczarczyk-Saczonek A, Znajewska-Pander A, Owczarek W, Maciejewska-Radomska A, Placek W. Owczarczyk-Saczonek A, et al. Among authors: owczarek w. Acta Dermatovenerol Alp Pannonica Adriat. 2018 Dec;27(4):215-219. Acta Dermatovenerol Alp Pannonica Adriat. 2018. PMID: 30564836 Free article.
Comparative effectiveness of adalimumab versus ustekinumab in the treatment of severe chronic plaque psoriasis: The results based on data from the program "treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in Poland.
Owczarek W, Nowakowska A, Walecka I, Ciechanowicz P, Reich A, Lesiak A, Borkowska E, Śliwczyński A, Narbutt J. Owczarek W, et al. Dermatol Ther. 2022 Jun;35(6):e15481. doi: 10.1111/dth.15481. Epub 2022 Apr 11. Dermatol Ther. 2022. PMID: 35363386
Risankizumab Therapy for Moderate-to-Severe Psoriasis-A Multi-Center, Long-Term, Real-Life Study from Poland.
Adamczyk M, Bartosińska J, Raczkiewicz D, Adamska K, Adamski Z, Czubek M, Kręcisz B, Kłujszo E, Lesiak A, Narbutt J, Noweta M, Owczarczyk-Saczonek A, Owczarek W, Reich A, Samotij D, Siekierko A, Szczęch J, Walecka I, Ciechanowicz P, Woźniacka A, Liszewska A, Krasowska D. Adamczyk M, et al. Among authors: owczarek w. J Clin Med. 2023 Feb 20;12(4):1675. doi: 10.3390/jcm12041675. J Clin Med. 2023. PMID: 36836209 Free PMC article.
66 results